InfoTechTarget and Informa Tech's Digital Businesses Combine.

Together, we power an unparalleled network of 220+ online properties covering 10,000+ granular topics, serving an audience of 50+ million professionals with original, objective content from trusted sources. We help you gain critical insights and make more informed decisions across your business priorities.

2021 Amendments to Chinese patent law—What’s in it for the life sciences?

Presented by

Keith Haddaway (Venable)

About this talk

Amendments to Chinese patent law went into effect on June 1, 2021. Some of these amendments have important consequences for life sciences patent practice in China. The most striking change is the establishment of a system for resolving patent disputes in the life sciences. While similar to the Hatch-Waxman process, the Chinese law also encompasses biologics and traditional Chinese medicines in addition to small-chemical drugs. Amendments are also directed at extensions of patent terms under particular circumstances. This presentation will include a description of the new Chinese system and a comparison to the US system.
World Intellectual Property Review Insights

World Intellectual Property Review Insights

15043 subscribers85 talks
Providing insight on Intellectual Property and the Life Sciences
Content for the home of World IP Review and Life Sciences IP Review
Related topics